source
- JAK inhibitor sequencing and transplant timing in myelofibrosis discussed at 2026 conferenceDr. Andrew Kuykendall of Moffitt Cancer Center explained how doctors decide the order of JAK inhibitor therapies and when to consider allogeneic stem cell transplant for myelofibrosis patients. At…
- Experts Highlight Emerging Strategies and Unmet Needs in Mantle Cell LymphomaDr. Lore Gruenbaum, PhD, recently discussed the evolving landscape of mantle cell lymphoma (MCL) in a presentation titled “New Understandings of Treatments, End Points, and Disease Biology Expand M…